WCG Executive and Leadership Team

Sam Srivastava, the Chief Executive Officer at WCG, directs the company's overarching strategy and operational execution. Srivastava guides WCG's mission to measurably improve the quality and efficiency of clinical trials, directly impacting the speed at which new treatments and therapies reach patients. This leadership role involves aligning all departments toward the core objective of facilitating biopharmaceutical companies, CROs, and institutions in their development processes. Srivastava ensures that WCG's strategic initiatives support innovation and maintain the highest standards of operational excellence across the organization. The Chief Executive Officer's focus remains on driving growth and enhancing WCG's market position as a leader in clinical trial acceleration. Sam Srivastava's vision propels the company's commitment to advancing patient care through streamlined research and development.

Todd Joron, the Co-Founder & Wcg Imaging President & Chief Operating Officer at WCG, directs the operational execution and imaging services division. Joron oversees the day-to-day operations of WCG, ensuring seamless integration of services that enhance clinical trial quality and efficiency. This leadership position involves managing the Wcg Imaging division, a critical component in the development of new treatments and therapies. The Co-Founder & Wcg Imaging President & Chief Operating Officer focuses on optimizing operational workflows, resource allocation, and service delivery across all WCG platforms. Todd Joron's dual role ensures that both the core operational functions and the specialized imaging services contribute effectively to WCG's mission of accelerating therapeutic development for patients worldwide.

Cynthia Carter, the President, MI & I at WCG, leads the Medical Imaging & Informatics division, driving innovation and operational excellence within this specialized area. Carter oversees the strategic direction and execution of services that enhance the quality and efficiency of clinical trials through advanced imaging and data analysis. This leadership role is pivotal in supporting biopharmaceutical companies and CROs in their efforts to develop new treatments and therapies. The President, MI & I ensures that WCG's imaging and informatics solutions meet the highest industry standards, providing critical insights for therapeutic development. Cynthia Carter's focus is on leveraging technology and expertise to accelerate patient access to novel medical advancements.

Rbih Mansur, the President at WCG, directs key strategic initiatives and operational oversight across designated business units. Mansur focuses on enhancing the efficiency and quality of clinical trials, contributing directly to the accelerated development of new treatments and therapies. This leadership position involves driving performance improvements and ensuring alignment with WCG's core mission. The President works to strengthen relationships with partners, including biopharmaceutical companies and CROs, by delivering exceptional service and innovative solutions. Rbih Mansur's leadership is instrumental in expanding WCG's impact and solidifying its position as a leader in the clinical research industry, ultimately benefiting patients seeking novel medical interventions.

Theresa Moench, the President, Clinical Research Solutions at WCG, leads the comprehensive suite of services designed to optimize clinical trial execution. Moench drives the strategic vision and operational management for solutions that measurably improve the quality and efficiency of research processes. This role is critical in supporting biopharmaceutical companies, CROs, and institutions in their pursuit of developing new treatments and therapies for patients. The President, Clinical Research Solutions ensures that WCG's offerings are at the forefront of innovation, providing partners with the tools and expertise needed for successful trial outcomes. Theresa Moench's leadership focuses on delivering integrated solutions that accelerate the path from discovery to patient care.

Robert VanHees, the President, Chief Financial & Chief Administrative Officer at WCG, oversees the company's financial health and administrative operations. VanHees directs financial strategy, resource allocation, and fiscal management to ensure WCG's sustainable growth and operational efficiency. This dual role also encompasses the management of administrative functions, ensuring a stable and effective organizational infrastructure. The President, Chief Financial & Chief Administrative Officer plays a key part in supporting WCG's mission to improve clinical trial quality and accelerate the development of new treatments and therapies. Robert VanHees's financial acumen and administrative oversight are vital for WCG's ability to serve its partners and advance patient care through innovative research.

Paul Mancinelli, the Chief Technology Officer at WCG, architects the technological infrastructure and digital strategy that underpins WCG's operations. Mancinelli oversees the development and implementation of innovative technology solutions designed to enhance the quality and efficiency of clinical trials. This involves managing the company's data platforms, cybersecurity measures, and digital transformation initiatives, ensuring robust and scalable systems. The Chief Technology Officer's responsibilities extend to evaluating emerging technologies that can further accelerate the development of new treatments and therapies. Mancinelli drives technological advancements that support WCG's biopharmaceutical, CRO, and institutional partners. Paul Mancinelli's leadership ensures WCG remains at the forefront of technological innovation in the clinical research sector, optimizing processes and data integrity.

Antonio Castillo, the Director, Chief Revenue Officer Partnerships at WCG, spearheads the strategic development and management of key revenue-generating partnerships. Castillo focuses on cultivating and expanding relationships with biopharmaceutical companies, CROs, and research institutions to drive WCG's commercial growth. This role involves identifying new business opportunities and ensuring that partnership agreements align with WCG's mission to improve clinical trial quality and efficiency. The Director, Chief Revenue Officer Partnerships works closely with sales and business development teams to achieve revenue targets and enhance market penetration. Antonio Castillo's expertise in partnership management is critical for WCG's expansion and its ability to facilitate the development of new therapies for patients globally.

Elisa Calicchio, the Chief Human Resources Officer at WCG, leads the strategic development and execution of human capital initiatives. Calicchio oversees all aspects of talent management, organizational development, and employee engagement, ensuring WCG cultivates a high-performing and supportive work environment. This role is crucial for attracting, retaining, and developing the skilled professionals necessary to drive innovation in clinical trials. The Chief Human Resources Officer ensures that WCG's workforce is aligned with the company's mission to improve the quality and efficiency of clinical trial processes. Elisa Calicchio's leadership fosters a culture that supports the rapid development of new treatments and therapies, directly contributing to WCG's success in serving its partners and patients.